Novelos reports positive results from NOV-002 Phase 2 neoadjuvant breast cancer trial

[News]

Novelos Therapeutics, Inc., a biopharmaceutical company developing therapeutics to treat cancer and hepatitis, today announced positive results in a Phase 2 trial of NOV-002 in combination with neoadjuvant chemotherapy treatment in patients with stage IIB-IIIC HER-2/neu negative invasive breast cancer, conducted by the Braman Family Breast Cancer Institute at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine.

More... (http://www.news-medical.net/news/20100712/Novelos-reports-positive-results-from-NOV-002-Phase-2-neoadjuvant-breast-cancer-trial.aspx)